AAAAAA

   
Results: 1-9 |
Results: 9
A PRELIMINARY EVALUATION OF NELFINAVIR MESYLATE, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 PROTEASE, TO TREAT HIV-INFECTION
Authors: MARKOWITZ M CONANT M HURLEY A SCHLUGER R DURAN M PETERKIN J CHAPMAN S PATICK A HENDRICKS A YUEN GJ HOSKINS W CLENDENINN N HO DD
Citation: M. Markowitz et al., A PRELIMINARY EVALUATION OF NELFINAVIR MESYLATE, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 PROTEASE, TO TREAT HIV-INFECTION, The Journal of infectious diseases, 177(6), 1998, pp. 1533-1540
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS
Authors: YUEN GJ ANDERSON R SANDOVAL T WU E SHETTY BV KERR BM
Citation: Gj. Yuen et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 40-40
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS
Authors: KERR BM YUEN GJ SANDOVAL T WU E SHETTY BV ANDERSON R
Citation: Bm. Kerr et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 42-42
PHARMACOKINETICS OF LAMIVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH RENAL DYSFUNCTION
Authors: HEALD AE HSYU PH YUEN GJ ROBINSON P MYDLOW P BARTLETT JA
Citation: Ae. Heald et al., PHARMACOKINETICS OF LAMIVUDINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH RENAL DYSFUNCTION, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1514-1519
PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE
Authors: MOORE KHP YUEN GJ RAASCH RH ERON JJ MARTIN D MYDLOW PK HUSSEY EK
Citation: Khp. Moore et al., PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 550-558
POPULATION (POP) PHARMACOKINETICS (PK) OF LAMIVUDINE (3TC) IN HIV-INFECTED PATIENTS - RESULTS FROM 2 PHASE-III CLINICAL-TRIALS
Authors: YUEN GJ BENOIT S RUBIN M
Citation: Gj. Yuen et al., POPULATION (POP) PHARMACOKINETICS (PK) OF LAMIVUDINE (3TC) IN HIV-INFECTED PATIENTS - RESULTS FROM 2 PHASE-III CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 60-60
PHARMACOKINETICS, ABSOLUTE BIOAVAILABILITY, AND ABSORPTION CHARACTERISTICS OF LAMIVUDINE
Authors: YUEN GJ MORRIS DM MYDLOW PK HAIDAR S HALL ST HUSSEY EK
Citation: Gj. Yuen et al., PHARMACOKINETICS, ABSOLUTE BIOAVAILABILITY, AND ABSORPTION CHARACTERISTICS OF LAMIVUDINE, Journal of clinical pharmacology, 35(12), 1995, pp. 1174-1180
POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING
Authors: YUEN GJ DRUSANO GL FLETCHER C CAPPARELLI E CONNOR JD LALEZARI JP DREW L FOLLANSBEE S BUSCH D JACOBSON M SPECTOR SA SQUIRES K BUHLES W
Citation: Gj. Yuen et al., POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2350-2352
A PHASE I II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: PLUDA JM COOLEY TP MONTANER JSG SHAY LE REINHALTER NE WARTHAN SN RUEDY J HIRST HM VICARY CA QUINN JB YUEN GJ WAINBERG MA RUBIN M YARCHOAN R
Citation: Jm. Pluda et al., A PHASE I II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, The Journal of infectious diseases, 171(6), 1995, pp. 1438-1447
Risultati: 1-9 |